These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 9170428

  • 1. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
    Carril JM, Quirce R, Serrano J, Banzo I, Jiménez-Bonilla JF, Tabuenca O, Barquín RG.
    J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 3. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 4. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K, Katoh C, Kanegae K, Tsukamoto E, Shiga T, Mochizuki T, Itoh K, Tamaki N.
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE, Gurll N, Schurrer ME, Aktay R, Kirchner PT.
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
    Hsu CC, Chen YW, Huang YF, Chuang YW.
    Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J.
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer.
    van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM.
    Nucl Med Commun; 1993 May; 14(5):365-72. PubMed ID: 8510876
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma.
    Uğur O, Kostakoğlu L, Caner B, Güler N, Gülaldi NC, Ozmen M, Uysal U, Elahi N, Erbengi G, Bejdik C.
    Nucl Med Commun; 1996 May; 17(5):373-7. PubMed ID: 8736512
    [Abstract] [Full Text] [Related]

  • 16. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L, Waxman A, Braunstein G.
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E, Mechlis-Frish S, Zatz S, Shimoni A, Segal K, Avraham A, Levy R, Feinmesser R.
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [Abstract] [Full Text] [Related]

  • 19. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ, Chung JK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC, Cho BY.
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [Abstract] [Full Text] [Related]

  • 20. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
    Hoefnagel CA, Delprat CC, Marcuse HR, de Vijlder JJ.
    J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.